The first clinical experience with a novel directional coronary atherectomy catheter: Preliminary Japanese...

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Medical Devices

Background:

• Percutaneous coronary intervention (PCI) for bifurcation lesions remains challenging despite advances in drug-eluting stents (DES).
• Existing PCI techniques for bifurcations can be complex and may require intricate stenting strategies.

Purpose of the Study:

• To evaluate the initial clinical safety and efficacy of a novel directional coronary atherectomy (DCA) catheter.
• To assess the feasibility of using DCA as an adjunct or alternative to complex stenting in bifurcation lesions.

Main Methods:

• A prospective registry of 14 patients with de novo bifurcation lesions was established.
• A novel DCA catheter was utilized for lesion treatment.
• Device success, procedural success, and in-hospital outcomes were meticulously recorded.

Main Results:

• The novel DCA catheter demonstrated a 100% device success rate and 100% procedural success rate.
• No major procedure-related adverse events occurred during DCA.
• Twenty-nine percent of patients (4/14) were treated without stent implantation, and the remaining 10 patients underwent simple stenting.
• No in-hospital major adverse cardiac events were observed in the study cohort.

Conclusions:

• The novel DCA catheter appears to be a safe and effective option for treating coronary artery bifurcation lesions.
• DCA may simplify PCI procedures for bifurcations, potentially reducing the need for complex stenting techniques.
• Further studies are warranted to confirm the long-term clinical significance and broader applicability of this novel DCA catheter.